Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA△COMPANIESCompanies rated · 435 (no change)△PROJECTSProjects rated · 70 (no change)△CATALOGUE874 grants in catalogue · 19 open right now•POWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
←All companies
FILE C-7ZR4·COMPANY·CURATED BY ETERNAL SEARCH

Akero Therapeutics

FGF21 analogue, metabolic disease, MASH

modulatingbiologic
AcquiredAcquired / exited

Derived from funding_stage=acquired (site-analyzer acquisition/dissolution evidence); operating-status detector had not run.

akerotx.com·San Francisco, California, United States·Founded 2017·Acquired·$6.1B total funding
01Overview02People03Projects04Concepts05Patents06Public records07Belief evolution
Plate C · C-7ZR4

Loading

Loading section...

0-100 chain-logic scale · 15 dimensions · scored on public evidence